On the upside
Workday (NYSE: WDAY) stock continued advancing after making its debut on Friday.
Cyclacel Pharmaceuticals (Nasdaq: CYCC) reported update data from a Phase 2 clinical trial of its myelodysplastic syndromes treatment sapacitabine.
On the downside
MetroPCS (NYSE: PCS) stock fell after Softbank offered $20.1 billion to acquire a 70% stake in MetroPCS rival Sprint (NYSE: S).
Turquoise Hill Resources (NYSE: TRQ) rejected a request by the Mongolian government to renegotiate the Oyu Tolgoi Investment Agreement.
Lazard Capital Markets analyst Michael Lewis downgraded Harris (NYSE: HRS) to a Sell rating.
In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 5 points to 828.